BLFS
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUSBioLife Solutions, Inc. (BLFS) [ST]
www.biolifesolutions.com ↗▲ 1.10%
prev close
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
Congressional Trades
1
All tracked trades
Members Trading
1
Unique members
Net Activity
-1
0 buys · 1 sells
Members Who Traded This Stock
1 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2022-12-12 | BLFSBioLife Solutions, Inc. | Sell | $1,001 - $15,000 | 1168d ago | — |
2022-12-12
Christopher L. Jacobs
BLFS
Amount
$1,001 - $15,000
Filed
1168d ago
Recent News
Powered by Polygon.io
BioLife Solutions Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations
BioLife Solutions to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update on February 26, 2026
BioLife Solutions Signs Multi-Year Supply Agreement with Qkine Limited to Expand its Product Portfolio into the Rapidly Growing Cytokines Market
Bio-Preservation Market to Reach US$ 44.45 Billion by 2035 | Cold Chain Expansion and Cell & Gene Therapy Commercialization Drive Growth Says Astute Analytica
BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2025 Unaudited Revenue from Continuing Operations
Trade Timeline
Congressional activity, newest first
Christopher L. Jacobs
2022-12-12 · Sale
$1,001 - $15,000